NeuroFront Therapeutics
PrivateCompany Overview
NeuroFront Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. It was founded in 2020.
NeuroFront Therapeutics is a clinical-stage biotechnology company that develops and commercializes innovative neuroscience therapies to address unmet medical needs in China and Asia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroFront Therapeutics Comparables
Compare NeuroFront Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 上海赛默罗生物科技有限公司 | 83% | |
| Novaremed AG | 83% | |
| Ignis Therapeutics | 80% |
For institutional investors. Book with your work email.
NeuroFront Therapeutics Funding Rounds
Historical fundraising activity
NeuroFront Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroFront Therapeutics's valuation, stock price, and market status.
Is NeuroFront Therapeutics a public or private company?
NeuroFront Therapeutics is a private company.
What is the current stock price of NeuroFront Therapeutics?
NeuroFront Therapeutics is a private company, so its shares have no public market price. Caplight tracks NeuroFront Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroFront Therapeutics worth (valuation)?
Valuation information for NeuroFront Therapeutics is not publicly available.
Can I buy NeuroFront Therapeutics stock?
NeuroFront Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroFront Therapeutics's last funding round?
Funding round information for NeuroFront Therapeutics is not publicly available.
Who are the main investors in NeuroFront Therapeutics?
Investor information for NeuroFront Therapeutics is not publicly disclosed.
Will NeuroFront Therapeutics IPO soon?
No public IPO plans have been announced for NeuroFront Therapeutics.
How can I track NeuroFront Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NeuroFront Therapeutics's shares on secondary markets.